Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways

American Journal of Physiology - Endocrinology and Metabolism

Volumn 305, Issue 3, 2013, Pages

  Nishizawa, Makoto ^a   Nakabayashi, Hajime ^b   Uehara, Keigo ^a   Nakagawa, Atsushi ^a   Uchida, Kenzo ^a   Koya, Daisuke ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Glucose induced earlyphase insulin secretion; Hepatic vagotomy; Unrestrained conscious rat; Vagal hormone reception

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMORECEPTOR; CONTROLLED STUDY; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; INSULIN LIKE ACTIVITY; INSULIN RELEASE; MALE; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; RAT; VAGOTOMY; VAGUS REFLEX;

GLUCOSE-INDUCED EARLY-PHASE INSULIN SECRETION; HEPATIC VAGOTOMY; UNRESTRAINED CONSCIOUS RAT; VAGAL HORMONE RECEPTION;

ANIMALS; AREA UNDER CURVE; BLOOD GLUCOSE; ELECTROPHYSIOLOGICAL PHENOMENA; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; INCRETINS; INFUSIONS, INTRAVENOUS; INSULIN; LIVER; MALE; PANCREAS; PORTAL VEIN; POSTPRANDIAL PERIOD; RATS; REFLEX; SIGNAL TRANSDUCTION; VAGOTOMY; VAGUS NERVE;

EID: 84880988162     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00565.2012     Document Type: Article

References (56)

1. Agostoni E, Chinnock JE, De Daly MB, Murray JG. Functional and histological studies of the vagus nerve and its branches to the heart, lungs and abdominal viscera in the cat. J Physiol 135: 182-205, 1957.
2. Ahren B. Autonomic regulation of islet hormone secretion-implications for health and disease. Diabetologia 43: 393-410, 2000.
3. Ahren B. Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice. Am J Physiol Regul Integr Comp Physiol 286: R269-R272, 2004.
4. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 132: 2131-2157, 2007.
5. Balkan B, Li X. Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms. Am J Physiol Regul Integr Comp Physiol 279: R1449-R1454, 2000.
6. Berthoud HR, Neuhuber WL. Functional and chemical anatomy of the afferent vagal system. Auton Neurosci 85: 1-17, 2000.
7. Burcelin R, Da Costa A, Drucker D, Thorens B. Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon- like peptide-1 receptor. Diabetes 50: 1720-1728, 2001.
8. Cerasi E, Luft R. "What is inherited - what is added" hypothesis for the pathogenesis of diabetes mellitus. Diabetes 16: 615-627, 1967.
9. Coate KC, Kraft G, Irimia JM, Smith MS, Farmer B, Neal DW, Roach PJ, Shiota M, Cherrington AD. Portal vein glucose entry triggers a coordinated cellular response that potentiates hepatic glucose uptake and storage in normal but not high-fat/high-fructose-fed dogs. Diabetes 62: 392-400, 2013.
10. Creutzfeldt W. The incretin concept today. Diabetologia 16: 75-85, 1979.
11. D'Alessio DA, Prigeon RL, Ensinck JW. Enteral enhancement of glucose disposition by both insulin-dependent and insulin-independent processes. A physiological role of glucagon-like peptide I Diabetes 44: 1433-1437, 1995.
12. Deacon CF, Pridal L, Klarskov L, Olesen M, Holst JJ. Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig. Am J Physiol Endocrinol Metab 271: E458-E464, 1996.
13. Elrick H, Stimmler L, Hlad CJ Jr, Arai Y. Plasma insulin response to oral and intravenous glucose administration. J Clin Endocrinol Metab 24: 1076-1082, 1964.
14. Gilon P, Henquin JC. Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocr Rev 22: 565-604, 2001.
15. Hansen L, Deacon CF, Orskov C, Holst JJ. Glucagon-like peptide-1- (7-36)amide is transformed to glucagon-like peptide-1-(9 -36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine. Endocrinology 140: 5356-5363, 1999.
16. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 87: 1409-1439, 2007.
17. Holst JJ, Deacon CF. Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors. Diabetologia 48: 612-615, 2005.
18. Holst JJ, Orskov C, Nielsen OV, Schwartz TW. Truncated glucagonlike peptide I, an insulin-releasing hormone from the distal gut. FEBS Lett 211: 169-174, 1987.
19. Holst JJ, Vilsboll T, Deacon CF. The incretin system and its role in type 2 diabetes mellitus. Mol Cell Endocrinol 297: 127-136, 2009.
20. Imeryuz N, Yegen BC, Bozkurt A, Coskun T, Villanueva-Penacarrillo ML, Ulusoy NB. Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am J Physiol Gastrointest Liver Physiol 273: G920-G927, 1997.
21. Ionut V, Hucking K, Liberty IF, Bergman RN. Synergistic effect of portal glucose and glucagon-like peptide-1 to lower systemic glucose and stimulate counter-regulatory hormones. Diabetologia 48: 967-975, 2005.
22. Ionut V, Liberty IF, Hucking K, Lottati M, Stefanovski D, Zheng D, Bergman RN. Exogenously imposed postprandial-like rises in systemic glucose and GLP-1 do not produce an incretin effect, suggesting an indirect mechanism of GLP-1 action. Am J Physiol Endocrinol Metab 291: E779-E785, 2006.
23. Kakei M, Yada T, Nakagawa A, Nakabayashi H. Glucagon-like peptide- 1 evokes action potentials and increases cytosolic Ca2+ in rat nodose ganglion neurons. Auton Neurosci 102: 39-44, 2002.
24. Kastin AJ, Akerstrom V, Pan W. Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier. J Mol Neurosci 18: 7-14, 2002.
25. Kreymann B, Williams G, Ghatei MA, Bloom SR. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2: 1300-1304, 1987.
26. Lee HC, Curry DL, Stern JS. Direct effect of CNS on insulin hypersecretion in obese Zucker rats: involvement of vagus nerve. Am J Physiol Endocrinol Metab 256: E439-E444, 1989.
27. Lee KC, Miller RE. The hepatic vagus nerve and the neural regulation of insulin secretion. Endocrinology 117: 307-314, 1985.
28. Matsuhisa M, Yamasaki Y, Shiba Y, Nakahara I, Kuroda A, Tomita T, Iida M, Ikeda M, Kajimoto Y, Kubota M, Hori M. Important role of the hepatic vagus nerve in glucose uptake and production by the liver. Metabolism 49: 11-16, 2000.
29. McIntyre N, Holdsworth CD, Turner DS. New interpretation of oral glucose tolerance. Lancet 2: 20-21, 1964.
30. Merchenthaler I. Neurons with access to the general circulation in the central nervous system of the rat: a retrograde tracing study with fluorogold. Neuroscience 44: 655-662, 1991.
31. Miller RE. Pancreatic neuroendocrinology: peripheral neural mechanisms in the regulation of the islets of Langerhans. Endocr Rev 2: 471-494, 1981.
32. Nakabayashi H, Nishizawa M, Nakagawa A, Takeda R, Niijima A. Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1. Am J Physiol Endocrinol Metab 271: E808-E813, 1996.
33. Nakagawa A, Satake H, Nakabayashi H, Nishizawa M, Furuya K, Nakano S, Kigoshi T, Nakayama K, Uchida K. Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells. Auton Neurosci 110: 36-43, 2004.
34. Nauck M, Stockmann F, Ebert R, Creutzfeldt W. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 29: 46-52, 1986.
35. Nauck MA, El-Ouaghlidi A. The therapeutic actions of DPP-IV inhibition are not mediated by glucagon-like peptide-1. Diabetologia 48: 608-611, 2005.
36. Nauck MA, Niedereichholz U, Ettler R, Holst JJ, Orskov C, Ritzel R, Schmiegel WH. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol Endocrinol Metab 273: E981-E988, 1997.
37. Niijima A. Afferent impulse discharges from glucoreceptors in the liver of the guinea pig. Ann NY Acad Sci 157: 690-700, 1969.
38. Niijima A. The effect of glucose on the activity of the adrenal nerve and pancreatic branch of the vagus nerve in the rabbit. Neurosci Lett 1: 159-162, 1975.
39. Niijima A. Glucose-sensitive afferent nerve fibres in the hepatic branch of the vagus nerve in the guinea-pig. J Physiol 332: 315-323, 1982.
40. Niijima A. Glucose sensitive afferent nerve fibers in the liver and regulation of blood glucose. Brain Res Bull 5, Suppl 4: 175-179, 1980.
41. Nishizawa M, Moore MC, Shiota M, Gustavson SM, Snead WL, Neal DW, Cherrington AD. Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs. Am J Physiol Endocrinol Metab 284: E1027-E1036, 2003.
42. Nishizawa M, Nakabayashi H, Uchida K, Nakagawa A, Niijima A. The hepatic vagal nerve is receptive to incretin hormone glucagon-like peptide- 1, but not to glucose-dependent insulinotropic polypeptide, in the portal vein. J Auton Nerv Syst 61: 149-154, 1996.
43. Orskov C, Poulsen SS, Moller M, Holst JJ. Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I. Diabetes 45: 832-835, 1996.
44. Perley MJ, Kipnis DM. Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects. J Clin Invest 46: 1954-1962, 1967.
45. Pratley RE, Weyer C. The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus. Diabetologia 44: 929-945, 2001.
46. Prechtl JC, Powley TL. The fiber composition of the abdominal vagus of the rat. Anat Embryol (Berl) 181: 101-115, 1990.
47. Sauter JF, Niijima A, Berthoud HR, Jeanrenaud B. Vagal neurons and pathways to the rat's lower viscera: an electrophysiological study. Brain Res Bull 11: 487-491, 1983.
48. Unger RH, Eisentraut AM. Entero-insular axis. Arch Intern Med 123: 261-266, 1969.
49. Vilsboll T, Krarup T, Deacon CF, Madsbad S, Holst JJ. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 50: 609-613, 2001.
50. Vilsboll T, Krarup T, Madsbad S, Holst JJ. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects. Regul Pept 114: 115-121, 2003.
51. Wan S, Coleman FH, Travagli RA. Glucagon-like peptide-1 excites pancreas-projecting preganglionic vagal motoneurons. Am J Physiol Gastrointest Liver Physiol 292: G1474-G1482, 2007.
52. Wang J, Zheng H, Berthoud HR. Functional vagal input to chemically identified neurons in pancreatic ganglia as revealed by Fos expression. Am J Physiol Endocrinol Metab 277: E958-E964, 1999.
53. Wettergren A, Wojdemann M, Holst JJ. Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow. Am J Physiol Gastrointest Liver Physiol 275: G984-G992, 1998.
54. Woods SC, Porte D Jr. Neural control of the endocrine pancreas. Physiol Rev 54: 596-619, 1974.
55. Yamazaki M, Sakaguchi T. Pancreatic vagal functional distribution in the secretion of insulin evoked by portal infusion of D-glucose. Brain Res 484: 357-360, 1989.
56. Zhang J, Ritter RC. Circulating GLP-1 and CCK-8 reduce food intake by capsaicin-insensitive, nonvagal mechanisms. Am J Physiol Regul Integr Comp Physiol 302: R264-R273, 2012.